Our observed increased expression of GRβ mRNA in muscle of symptomatic SMA mice (Fig. 1b), may thus be a compensatory attempt to reduce the activity of catabolic pathways (e.g. MuRF-1 and atrogin-1) that accompanies muscle pathology in these mice. This evidence concerns the gene GZMB and proximal spinal muscular atrophy.